These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23772446)
1. Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study. Askeland G Expert Rev Clin Immunol; 2013 May; 9(5):402. PubMed ID: 23772446 [No Abstract] [Full Text] [Related]
2. Maintenance rituximab should be considered for patients with follicular lymphoma. Barr PM Clin Adv Hematol Oncol; 2014 Aug; 12(8):541-3. PubMed ID: 25356579 [No Abstract] [Full Text] [Related]
3. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy. Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028 [TBL] [Abstract][Full Text] [Related]
4. Rituximab by subcutaneous route. Solal-Celigny P Expert Rev Hematol; 2015 Apr; 8(2):147-53. PubMed ID: 25749209 [TBL] [Abstract][Full Text] [Related]
5. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies. Seiler T; Hiddemann W; Dreyling M Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916 [TBL] [Abstract][Full Text] [Related]
6. Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab. Jensen M; Elter T; Engert A; Reiser M Onkologie; 2006 Mar; 29(3):90-2. PubMed ID: 16514269 [TBL] [Abstract][Full Text] [Related]